+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Corticotropin"

Gout Therapeutics Market Report 2025 - Product Thumbnail Image

Gout Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gouty Arthritis Global Market Report 2024 - Product Thumbnail Image

Gouty Arthritis Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Congenital Adrenal Hyperplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Congenital Adrenal Hyperplasia - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

The Corticotropin market is a segment of the Endocrine and Metabolic Disorders Drugs market. Corticotropin is a hormone produced by the pituitary gland that helps regulate the body's response to stress. It is used to treat a variety of conditions, including adrenal insufficiency, Cushing's syndrome, and certain types of cancer. Corticotropin is also used to treat certain types of anemia and to stimulate the production of red blood cells. Corticotropin is available in both injectable and oral forms. The Corticotropin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Novartis, Pfizer, Merck, Sanofi, and Eli Lilly. These companies are engaged in research and development activities to develop new products and improve existing ones. They are also investing in marketing and promotional activities to increase their market share. Show Less Read more